Skip to Content
Søg Menu

iTAPP-studiet: En evaluering af effekten af at implementere 15-metoden i Dansk Almen Praksis

/ Anette Søgaard Nielsen / Peter Næsborg Schøler
Alkohol

The Choice of Immunotherapy and PARP Inhibitor for Gynecological Cancer

/ BestPractice Nordic
ESMO24Gynækologisk cancer

Ten-Year Survival Data from a Groundbreaking Trial for the Treatment of Metastatic Melanoma

/ BestPractice Nordic
ESMO24Melanom

Resources are Limited in Iceland Regarding Research and Patient Management for Breast Cancer—A Closer Nordic Collaboration Would Therefore be Highly Valuable

/ Jan Andreasen
NBCN

EAN 2025 Will Once Again Be Held in Helsinki

/ Reetta Kälviäinen
EAN24EAN25 Play the Video 03:39

No Major Breakthroughs in Lung Cancer Compared to ESMO 2023

/ BestPractice Nordic
ESMO24Lungecancer
Josep M Llovet

Perhaps a New Treatment Option for Patients with Intermediate Hepatocellular Carcinoma

/ Josep M. Llovet
ESMO24Levercancer Play the Video 04:57

The Ultimate Proof That Immunotherapy Can Be Curative for Metastatic Malignant Melanoma

/ BestPractice Nordic
ESMO24Melanom

Norwegian Perspectives on Urogenital Cancer at ESMO 2024

/ BestPractice Nordic
ESMO24ProstatacancerNyrecancerBlærecancer
Annarita Antelmi

A Large Proportion of Patients with Prurigo Nodularis Receive Several Different Treatment Combinations and Switches and a High Number of Healthcare Visits

/ Annarita Antelmi
EADV24 Play the Video 07:01
Back to top